Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Faricimab PTI (Prior Faricimab Q8W)	493
Overall Study	STARTED	Faricimab PTI (Prior Faricimab PTI)	506
Overall Study	STARTED	Faricimab PTI (Prior Aflibercept Q8W)	475
Overall Study	Received at Least One Dose of Study Drug	Faricimab PTI (Prior Faricimab Q8W)	491
Overall Study	Received at Least One Dose of Study Drug	Faricimab PTI (Prior Faricimab PTI)	500
Overall Study	Received at Least One Dose of Study Drug	Faricimab PTI (Prior Aflibercept Q8W)	473
Overall Study	COMPLETED	Faricimab PTI (Prior Faricimab Q8W)	405
Overall Study	COMPLETED	Faricimab PTI (Prior Faricimab PTI)	407
Overall Study	COMPLETED	Faricimab PTI (Prior Aflibercept Q8W)	392
Overall Study	NOT COMPLETED	Faricimab PTI (Prior Faricimab Q8W)	88
Overall Study	NOT COMPLETED	Faricimab PTI (Prior Faricimab PTI)	99
Overall Study	NOT COMPLETED	Faricimab PTI (Prior Aflibercept Q8W)	83

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04432831/flow